HomeMOR • NASDAQ
Morphosys Ag
$17.89
After Hours:
$17.89
(0.00%)0.00
Closed: May 3, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
US listed securityDE headquartered
Previous close
$17.87
Day range
$17.80 - $17.93
Year range
$4.18 - $18.31
Market cap
2.67B USD
Avg Volume
559.99K
In the news
Financials
Income Statement
Revenue
Net income
(EUR)Mar 2024Y/Y change
Revenue
27.54M-55.81%
Operating expense
289.14M160.87%
Net income
-314.96M-608.87%
Net profit margin
-1.14K-1,504.03%
Earnings per share
-8.27-529.19%
EBITDA
-263.38M-294.65%
Effective tax rate
0.51%
Total assets
Total liabilities
(EUR)Mar 2024Y/Y change
Cash and short-term investments
131.26M-83.42%
Total assets
1.83B-17.85%
Total liabilities
2.09B-1.84%
Total equity
-261.67M
Shares outstanding
37.62M
Price to book
-2.57
Return on assets
-34.27%
Return on capital
-41.11%
Net change in cash
(EUR)Mar 2024Y/Y change
Net income
-314.96M-608.87%
Cash from operations
-73.62M-3.35%
Cash from investing
41.00M314.83%
Cash from financing
3.50M107.73%
Net change in cash
-27.24M75.37%
Free cash flow
-401.31M-1,492.74%
About
MorphoSys AG is a German biopharmaceutical company founded in 1992. The company is headquartered near Munich, Germany, and has a wholly owned subsidiary, MorphoSys US Inc., in Boston, Massachusetts, in the US. The company has various antibody, protein and peptide technologies that it uses to discover and develop both proprietary and partnered drug candidates. The company has more than 100 drugs in its wider pipeline that are being investigated for a variety of diseases. While many of these are being developed in partnership with pharma and biotech companies, MorphoSys also has a proprietary pipeline with a focus on cancer and autoimmune diseases. MorphoSys AG is listed on the Frankfurt Stock Exchange and on the US Nasdaq stock exchange. Novartis agreed to acquire the company in February 2024. Wikipedia
Founded
1992
Employees
464
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu